Climate Change Data

Epigenomics AG

Climate Impact & Sustainability Data (2017-2023e, 2019 to 2025e, 2021-06 to 2021-06, 2022, 2022e, 2023-01 to 2023-03)

Reporting Period: 2017-2023e

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

  • Insufficient funds to complete clinical trials for Epi proColon NEXT-GEN.
Mitigation Strategies
  • Anticipating additional debt funding in 2023e.

Supply Chain Management

Climate-Related Risks & Opportunities

Sustainable Products & Innovation

  • Epi proColon NEXT-GEN

Reporting Period: 2019 to 2025e

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Considerable funding required for clinical development of Epi proColon “Next-Gen”, constrained funding environment.
Mitigation Strategies
  • Deal with New Day Diagnostics (NDD) to transfer assets and receive milestone payments and royalties.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Epi proColon “Next-Gen”

Awards & Recognition

  • Not disclosed

Reporting Period: 2021-06 to 2021-06

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Missing reimbursement in the US for Epi proColon.
  • Fewer doctors' visits and resulting check-ups due to the Covid-19 pandemic.
  • Low level of sales.
Mitigation Strategies
  • Seeking reimbursement via legislation (Donald Payne Colorectal Cancer Detection Act).
  • Appealing the negative NCD reimbursement decision.
  • Developing a Next-Gen version of Epi proColon to meet new reimbursement criteria.
  • Planning a capital measure (issuance of a convertible bond) to finance clinical study and operations.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2022

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

  • Financial difficulties requiring a financing partner.
  • Discontinuation of Epi proColon sales and recall of sold tests.
  • Employee reduction at Berlin and San Diego sites.
Mitigation Strategies
  • Implementation of restructuring measures to cut costs.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2022e

Environmental Metrics

Environmental Challenges

  • Significant financing requirements (EUR 130m) for the commercialization of Epi proColon “Next-Gen”.
Mitigation Strategies
  • Seeking to raise the required capital.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2023-01 to 2023-03

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

  • Restructuring of the company leading to discontinued research and development activities.
  • Significant financing requirements (EUR 130m) for the materialization of the business case.
  • Resignation of CEO and CFO.
Mitigation Strategies
  • Conserving cash to last until mid-2025.
  • Seeking out-licensing and/or asset sale for Epi proColon “Next-Gen”.

Supply Chain Management

Climate-Related Risks & Opportunities